# A Study of GSM-779690T in Healthy Adult Participants

> **NCT07690228** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Acta Pharmaceuticals** · enrollment: 72 (estimated)

## Conditions studied

- Healthy Adult Participants
- Alzheimer Disease

## Interventions

- **DRUG:** GSM-779690T
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07690228
- **Lead sponsor:** Acta Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-15
- **Primary completion:** 2026-08-15
- **Final completion:** 2027-07-15
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07690228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07690228, "A Study of GSM-779690T in Healthy Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07690228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*